日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia model

利用人源 CRISPR 基因编辑的 MLL 重排白血病模型,研究 MLL 融合变体及其融合伴侣对白血病可塑性的影响

Radszuweit, Pia; Fitzel, Rahel; Bruestl, Sarah; Hentrich, Thomas; Korkmaz, Fulya; Mankel, Barbara; González-Menéndez, Irene; Rudat, Saskia; Marschalek, Rolf; Erkner, Estelle; Keppeler, Hildegard; Schairer, Rebekka; Luib, Luise; Mezger, Markus; Quintanilla-Martinez, Leticia; Schulze-Hentrich, Julia; Lengerke, Claudia; Schneidawind, Dominik; Schneidawind, Corina

Bridging the marrow: a co-culture-platform of leukemia cells and MS5-derived stromal cells or adipocytes.

连接骨髓:白血病细胞与 MS5 衍生基质细胞或脂肪细胞的共培养平台

Zinngrebe Julia, Brenner Elena Dorothea, Schlichtig Ferdinand, Stifel Ulrich, Tews Daniel, Falk Jana, Schlotter Dominik, Fitzel Rahel, Meyer Lüder-Hinrich, Debatin Klaus-Michael, Fischer-Posovszky Pamela

Treatment response of advanced HNSCC towards immune checkpoint inhibition is associated with an activated effector memory T cell phenotype

晚期头颈部鳞状细胞癌对免疫检查点抑制剂的治疗反应与活化的效应记忆T细胞表型相关

Schumacher, Max; Beer, Sina; Moraes Ribeiro, Emmanuelle; Korkmaz, Fulya; Keppeler, Hildegard; Fitzel, Rahel; Erkner, Estelle; Radszuweit, Pia; Lengerke, Claudia; Schneidawind, Corina; Hoefert, Sebastian; Mauz, Paul Stefan; Schneidawind, Dominik

Considering the Experimental use of Temozolomide in Glioblastoma Research.

考虑替莫唑胺在胶质母细胞瘤研究中的实验性应用

Herbener Verena J, Burster Timo, Goreth Alicia, Pruss Maximilian, von Bandemer Hélène, Baisch Tim, Fitzel Rahel, Siegelin Markus D, Karpel-Massler Georg, Debatin Klaus-Michael, Westhoff Mike-Andrew, Strobel Hannah